Progress in clinical neurosciences: Status epilepticus: A critical review of management options

Canadian Journal of Neurological Sciences

Volumn 29, Issue 3, 2002, Pages 206-215

  Lawn, Nicholas D ^a   Wijdicks, Eelco F M ^a  

^a Department of Neurology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; ELECTROLYTE; FOSPHENYTOIN SODIUM; ISOFLURANE; KETAMINE; LIDOCAINE; LORAZEPAM; MAGNESIUM; MIDAZOLAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROMUSCULAR BLOCKING AGENT; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; PROPOFOL; PROPYLENE GLYCOL; SEDATIVE AGENT; SODIUM HYDROXIDE; THIOPENTAL; VALPROIC ACID;

CHOREOATHETOSIS; CLINICAL TRIAL; DRUG ABSORPTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; LIVER TOXICITY; MORBIDITY; MORTALITY; MYOCLONUS; NONHUMAN; OPISTHOTONUS; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; THROMBOPHLEBITIS;

DECISION TREES; ELECTROENCEPHALOGRAPHY; HUMANS; STATUS EPILEPTICUS;

EID: 0036687046     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0317167100001967     Document Type: Review

References (111)

1. Treatment of convulsive status epilepticus. Recommendations of the epilepsy foundation of America's working group on status epilepticus
2. A comparison of four treatments for generalized convulsive status epilepticus
3. Status epilepticus
4. Treatment of status epilepticus
5. Proposal for revised clinical and electroencephalographic classification of epileptic seizures: From the Commission on Classification and Terminology of the International League against Epilepsy
6. Prolonged epileptic seizures in primates: Ischemic cell change and its relation to ictal physiological events
7. Systemic factors and epileptic brain damage: Prolonged seizures in paralyzed, artificially ventilated baboons
8. Mortality and morbidity from serial seizures; an experimental study
9. Status epilepticus in well-oxygenated rats causes neuronal necrosis
10. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia
11. Incidence of status epilepticus in Rochester, Minnesota, 1965-1984
12. It's time to revise the definition of status epilepticus
13. Status epilepticus. A perspective from the neuroscience intensive care unit
14. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus
15. Status epilepticus: Causes, clinical features and consequences in 98 patients
16. Causes and consequences of status epilepticus in adults: A study of 86 cases
17. Treatment of nonfebrile status epilepticus in Rochester, Minn, from 1965 through 1984
18. Pseudostatus epilepticus
19. Diagnosis and treatment of status epilepticus on a neurological intensive care unit
20. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus
21. Prognostic value of EEG monitoring after status epilepticus: A prospective adult study
22. Electroclinical features of status epilepticus
23. Serial EEG during human status epilepticus: Evidence for PLEDs as an ictal pattern
24. Periodic lateralized epileptiform discharges - A critical review
25. The EEG and prognosis in status epilepticus
26. Physiology of status epilepticus in primates
27. Self-sustaining limbic status epilepticus induced by 'continuous' hippocampal stimulation: Electrographic and behavioral characteristics
28. The significance of myoclonic status epilepticus in postanoxic coma
29. Pentobarbital and EEG burst suppression in treatment of status epilepticus refractory to benzodiazepines and phenytoin
30. Burst-suppression patterns in status epilepticus: The burst-suppression duration ratio: A marker of the end of clinical status epilepticus
31. Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus
32. Epileptic EEG discharges during burst suppression
33. Short-term mortality after a first episode of status epilepticus
34. Determinants of mortality in status epilepticus
35. Status epilepticus at an urban public hospital in the 1980s
36. Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes
37. Prospective population-based study of intermittent and continuous convulsive status epilepticus in Richmond, Virginia
38. Morbidity of nonfebrile status epilepticus in Rochester, Minnesota, 1965-1984
39. Risk of unprovoked seizure after acute symptomatic seizure: Effect of status epilepticus
40. Seizure recurrence after a 1st unprovoked seizure: An extended follow-up
41. Seizure recurrence after a first unprovoked seizure
42. Effect of prehospital treatment on the outcome of status epilepticus in children
43. Status epilepticus: Management and outcome of 107 episodes
44. Current concepts: Status epilepticus
45. Treatment of status epilepticus: A prospective comparison of diazepam and phenytoin versus phenobarbitone and optional phenytoin
46. Double-blind study of lorazepam and diazepam in status epilepticus
47. Lorazepam in status epilepticus
48. The influence of diazepam or lorazepam on the frequency of endotracheal intubation in childhood status epilepticus
49. Diazepam versus lorazepam: Relationship of drug distribution to duration of clinical action
50. Comparative trial of intravenous lorazepam and clonazepam in status epilepticus
51. Pharmacokinetic optimization of benzodiazepine therapy for acute seizures. Focus on delivery routes
52. Comparison of midazolam and diazepam by the intramuscular route for the control of seizures in a mouse model of status epilepticus
53. Use of intramuscular midazolam for status epilepticus
54. Intramuscular use of fosphenytoin: An overview
55. Combination therapy for status epilepticus: Intravenous diazepam and phenytoin
56. Treatment of refractory generalized tonic-clonic status epilepticus with pentobarbital anesthesia after high-dose phenytoin
57. Management approaches to prolonged seizures and status epilepticus
58. Phenytoin penetration into brain after administration of phenytoin or fosphenytoin
59. Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin
60. Intravenous phenytoin: Clinical and pharmacokinetic aspects
61. Phenytoin administration by constant intravenous infusion: Selective rates of administration
62. Diazepam by continuous intravenous infusion for status epilepticus in anticonvulsant hypersensitivity syndrome
63. Valproic acid treatment of experimental status epilepticus
64. Comparison of valproate and phenobarbital treatment after status epilepticus in rats
65. Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients
66. The safety of rapid valproic acid infusion
67. Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus
68. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial
69. Effects of magnesium sulfate on pentylenetetrazol-induced status epilepticus
70. Parenteral magnesium sulfate fails to control electroshock and pentylenetetrazol seizures in mice
71. The expert consensus guideline series-treatment of epilepsy
72. Effects of midazolam on electroencephalograms of seriously ill patients
73. Midazolam coma for refractory status epilepticus in children
74. Treatment of refractory generalized status epilepticus with continuous infusion of midazolam
75. Intravenous midazolam for the treatment of refractory status epilepticus
76. Midazolam treatment of acute and refractory status epilepticus
77. Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus
78. Role of propofol in refractory status epilepticus
79. Treatment of refractory status epilepticus with propofol: Clinical and pharmacokinetic findings
80. Propofol and midazolam in the treatment of refractory status epilepticus
81. Excitatory events associated with propofol anaesthesia: A review
82. Propofol-induced neuroexcitation and receptor desensitization
83. Delayed seizures following sedation with propofol
84. Propofol-related convulsions
85. Effect of propofol on the electrocorticogram in epileptic patients undergoing cortical resection
86. Long-term propofol infusion and cardiac failure in adult head-injured patients
87. Very-high-dose phenobarbital for refractory status epilepticus in children
88. Barbiturate anesthesia in the treatment of status epilepticus: Clinical experience with 14 patients
89. Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus
90. Anesthetic barbiturates in refractory status epilepticus
91. Status epilepticus treated by intravenous infusions of thiopentone sodium
92. Comparison of cardiovascular effects of thiopental and pentobarbital at equivalent levels of CNS depression
93. Update on anaesthesia and the immune response
94. Pentobarbital therapy for status epilepticus in children: Timing of tapering
95. Status epilepticus: Summary
96. Management of status epilepticus
97. Pro- and anticonvulsant effects of anesthetics (part 1)
98. Neuropathological effects of anesthetics used to stop status epilepticus in rats
99. Effects of anesthetics on neuropathological sequelae of status epilepticus in rats
100. The anticonvulsant effects of volatile anesthetics on penicillin-induced status epilepticus in cats
101. Prolonged low flow isoflurane anesthesia for status epilepticus
102. Isoflurane for refractory status epilepticus: A clinical series
103. Comparison of isoflurane, halothane and nitrous oxide in status epilepticus
104. The epileptogenic properties of the volatile anesthetics sevoflurane and isoflurane in patients with epilepsy
105. Effect of sevoflurane on electrocorticogram in normal brain
106. Lidocaine in the treatment of status epilepticus
107. Lidocaine and seizures
108. Role of lidocaine in managing status epilepticus
109. Refractory status epilepticus: Response to ketamine